Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 168 entries
Sorted by: Best Match Show Resources per page
Resistivity contrast imaging in semiconductor structures using ultra-low energy scanning electron microscopy.

Ultramicroscopy

Jóźwik I, Jagielski J, Dumiszewska E, Kamiński M, Kentsch U.
PMID: 34134066
Ultramicroscopy. 2021 Sep;228:113333. doi: 10.1016/j.ultramic.2021.113333. Epub 2021 May 30.

The damage-induced voltage alteration (DIVA) contrast mechanism in scanning electron microscope (SEM) has been studied in broad range of the primary electron beam energies, with a special emphasis on the ultra-low energy range. The SEM imaging contrast related to...

Cite
Jóźwik I, Jagielski J, Dumiszewska E, et al. Resistivity contrast imaging in semiconductor structures using ultra-low energy scanning electron microscopy. Ultramicroscopy. 2021;228:113333doi: 10.1016/j.ultramic.2021.113333.
Jóźwik, I., Jagielski, J., Dumiszewska, E., Kamiński, M., & Kentsch, U. (2021). Resistivity contrast imaging in semiconductor structures using ultra-low energy scanning electron microscopy. Ultramicroscopy, 228113333. https://doi.org/10.1016/j.ultramic.2021.113333
Jóźwik, Iwona, et al. "Resistivity contrast imaging in semiconductor structures using ultra-low energy scanning electron microscopy." Ultramicroscopy vol. 228 (2021): 113333. doi: https://doi.org/10.1016/j.ultramic.2021.113333
Jóźwik I, Jagielski J, Dumiszewska E, Kamiński M, Kentsch U. Resistivity contrast imaging in semiconductor structures using ultra-low energy scanning electron microscopy. Ultramicroscopy. 2021 Sep;228:113333. doi: 10.1016/j.ultramic.2021.113333. Epub 2021 May 30. PMID: 34134066.
Copy Download .nbib Format: NLM
Trends and clinical characteristics of 57.9 million COVID-19 vaccine recipients: a federated analysis of patients' primary care records .

The British journal of general practice : the journal of the Royal College of General Practitioners

Curtis HJ, Inglesby P, Morton CE, MacKenna B, Green A, Hulme W, Walker AJ, Morley J, Mehrkar A, Bacon S, Hickman G, Bates C, Croker R, Evans D, Ward T, Cockburn J, Davy S, Bhaskaran K, Schultze A, Rentsch CT, Williamson EJ, Rowan A, Fisher L, McDonald HI, Tomlinson L, Mathur R, Drysdale H, Eggo RM, Wing K, Wong AY, Forbes H, Parry J, Hester F, Harper S, O'Hanlon S, Eavis A, Jarvis R, Avramov D, Griffiths P, Fowles A, Parkes N, Douglas IJ, Evans SJ, Smeeth L, Goldacre B.
PMID: 34750106
Br J Gen Pract. 2021 Dec 31;72(714):e51-e62. doi: 10.3399/BJGP.2021.0376. Print 2022 Jan.

BACKGROUND: On 8 December 2020 NHS England administered the first COVID-19 vaccination.AIM: To describe trends and variation in vaccine coverage in different clinical and demographic groups in the first 100 days of the vaccine rollout.DESIGN AND SETTING: With the...

Cite
Curtis HJ, Inglesby P, Morton CE, et al. Trends and clinical characteristics of 57.9 million COVID-19 vaccine recipients: a federated analysis of patients' primary care records . Br J Gen Pract. 2021;72(714):e51-e62doi: 10.3399/BJGP.2021.0376.
Curtis, H. J., Inglesby, P., Morton, C. E., MacKenna, B., Green, A., Hulme, W., Walker, A. J., Morley, J., Mehrkar, A., Bacon, S., Hickman, G., Bates, C., Croker, R., Evans, D., Ward, T., Cockburn, J., Davy, S., Bhaskaran, K., Schultze, A., Rentsch, C. T., Williamson, E. J., Rowan, A., Fisher, L., McDonald, H. I., Tomlinson, L., Mathur, R., Drysdale, H., Eggo, R. M., Wing, K., Wong, A. Y., Forbes, H., Parry, J., Hester, F., Harper, S., O'Hanlon, S., Eavis, A., Jarvis, R., Avramov, D., Griffiths, P., Fowles, A., Parkes, N., Douglas, I. J., Evans, S. J., Smeeth, L., Goldacre, B. (2022). Trends and clinical characteristics of 57.9 million COVID-19 vaccine recipients: a federated analysis of patients' primary care records . The British journal of general practice : the journal of the Royal College of General Practitioners, 72(714), e51-e62. https://doi.org/10.3399/BJGP.2021.0376
Curtis, Helen J, et al. "Trends and clinical characteristics of 57.9 million COVID-19 vaccine recipients: a federated analysis of patients' primary care records ." The British journal of general practice : the journal of the Royal College of General Practitioners vol. 72,714 (2022): e51-e62. doi: https://doi.org/10.3399/BJGP.2021.0376
Curtis HJ, Inglesby P, Morton CE, MacKenna B, Green A, Hulme W, Walker AJ, Morley J, Mehrkar A, Bacon S, Hickman G, Bates C, Croker R, Evans D, Ward T, Cockburn J, Davy S, Bhaskaran K, Schultze A, Rentsch CT, Williamson EJ, Rowan A, Fisher L, McDonald HI, Tomlinson L, Mathur R, Drysdale H, Eggo RM, Wing K, Wong AY, Forbes H, Parry J, Hester F, Harper S, O'Hanlon S, Eavis A, Jarvis R, Avramov D, Griffiths P, Fowles A, Parkes N, Douglas IJ, Evans SJ, Smeeth L, Goldacre B. Trends and clinical characteristics of 57.9 million COVID-19 vaccine recipients: a federated analysis of patients' primary care records . Br J Gen Pract. 2021 Dec 31;72(714):e51-e62. doi: 10.3399/BJGP.2021.0376. Print 2022 Jan. PMID: 34750106; PMCID: PMC8589463.
Copy Download .nbib Format: NLM
Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens.

The Journal of pathology

Servant R, Garioni M, Vlajnic T, Blind M, Pueschel H, Müller DC, Zellweger T, Templeton AJ, Garofoli A, Maletti S, Piscuoglio S, Rubin MA, Seifert H, Rentsch CA, Bubendorf L, Le Magnen C.
PMID: 33934365
J Pathol. 2021 Aug;254(5):543-555. doi: 10.1002/path.5698. Epub 2021 Jun 02.

Patient-derived organoids (PDOs) represent promising preclinical models in various tumor types. In the context of prostate cancer (PCa), however, their establishment has been hampered by poor success rates, which impedes their broad use for translational research applications. Along with...

Cite
Servant R, Garioni M, Vlajnic T, et al. Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens. J Pathol. 2021;254(5):543-555doi: 10.1002/path.5698.
Servant, R., Garioni, M., Vlajnic, T., Blind, M., Pueschel, H., Müller, D. C., Zellweger, T., Templeton, A. J., Garofoli, A., Maletti, S., Piscuoglio, S., Rubin, M. A., Seifert, H., Rentsch, C. A., Bubendorf, L., & Le Magnen, C. (2021). Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens. The Journal of pathology, 254(5), 543-555. https://doi.org/10.1002/path.5698
Servant, Raphaëlle, et al. "Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens." The Journal of pathology vol. 254,5 (2021): 543-555. doi: https://doi.org/10.1002/path.5698
Servant R, Garioni M, Vlajnic T, Blind M, Pueschel H, Müller DC, Zellweger T, Templeton AJ, Garofoli A, Maletti S, Piscuoglio S, Rubin MA, Seifert H, Rentsch CA, Bubendorf L, Le Magnen C. Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens. J Pathol. 2021 Aug;254(5):543-555. doi: 10.1002/path.5698. Epub 2021 Jun 02. PMID: 33934365; PMCID: PMC8361965.
Copy Download .nbib Format: NLM
Covid-19 by Race and Ethnicity: A National Cohort Study of 6 Million United States Veterans.

medRxiv : the preprint server for health sciences

Rentsch CT, Kidwai-Khan F, Tate JP, Park LS, King JT, Skanderson M, Hauser RG, Schultze A, Jarvis CI, Holodniy M, Re VL, Akgün KM, Crothers K, Taddei TH, Freiberg MS, Justice AC.
PMID: 32511524
medRxiv. 2020 May 18; doi: 10.1101/2020.05.12.20099135.

BACKGROUND: There is growing concern that racial and ethnic minority communities around the world are experiencing a disproportionate burden of morbidity and mortality from symptomatic SARS-Cov-2 infection or coronavirus disease 2019 (Covid-19). Most studies investigating racial and ethnic disparities...

Cite
Rentsch CT, Kidwai-Khan F, Tate JP, et al. Covid-19 by Race and Ethnicity: A National Cohort Study of 6 Million United States Veterans. medRxiv. 2020;doi: 10.1101/2020.05.12.20099135.
Rentsch, C. T., Kidwai-Khan, F., Tate, J. P., Park, L. S., King, J. T., Skanderson, M., Hauser, R. G., Schultze, A., Jarvis, C. I., Holodniy, M., Re, V. L., Akgün, K. M., Crothers, K., Taddei, T. H., Freiberg, M. S., & Justice, A. C. (2020). Covid-19 by Race and Ethnicity: A National Cohort Study of 6 Million United States Veterans. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2020.05.12.20099135
Rentsch, Christopher T, et al. "Covid-19 by Race and Ethnicity: A National Cohort Study of 6 Million United States Veterans." medRxiv : the preprint server for health sciences vol. (2020). doi: https://doi.org/10.1101/2020.05.12.20099135
Rentsch CT, Kidwai-Khan F, Tate JP, Park LS, King JT, Skanderson M, Hauser RG, Schultze A, Jarvis CI, Holodniy M, Re VL, Akgün KM, Crothers K, Taddei TH, Freiberg MS, Justice AC. Covid-19 by Race and Ethnicity: A National Cohort Study of 6 Million United States Veterans. medRxiv. 2020 May 18; doi: 10.1101/2020.05.12.20099135. PMID: 32511524; PMCID: PMC7273292.
Copy Download .nbib Format: NLM
Autonomous Detection and Classification of PI-RADS Lesions in an MRI Screening Population Incorporating Multicenter-Labeled Deep Learning and Biparametric Imaging: Proof of Concept.

Diagnostics (Basel, Switzerland)

Winkel DJ, Wetterauer C, Matthias MO, Lou B, Shi B, Kamen A, Comaniciu D, Seifert HH, Rentsch CA, Boll DT.
PMID: 33202680
Diagnostics (Basel). 2020 Nov 14;10(11). doi: 10.3390/diagnostics10110951.

BACKGROUND: Opportunistic prostate cancer (PCa) screening is a controversial topic. Magnetic resonance imaging (MRI) has proven to detect prostate cancer with a high sensitivity and specificity, leading to the idea to perform an image-guided prostate cancer (PCa) screening; Methods:...

Cite
Winkel DJ, Wetterauer C, Matthias MO, et al. Autonomous Detection and Classification of PI-RADS Lesions in an MRI Screening Population Incorporating Multicenter-Labeled Deep Learning and Biparametric Imaging: Proof of Concept. Diagnostics (Basel). 2020;10(11)doi: 10.3390/diagnostics10110951.
Winkel, D. J., Wetterauer, C., Matthias, M. O., Lou, B., Shi, B., Kamen, A., Comaniciu, D., Seifert, H. H., Rentsch, C. A., & Boll, D. T. (2020). Autonomous Detection and Classification of PI-RADS Lesions in an MRI Screening Population Incorporating Multicenter-Labeled Deep Learning and Biparametric Imaging: Proof of Concept. Diagnostics (Basel, Switzerland), 10(11), . https://doi.org/10.3390/diagnostics10110951
Winkel, David J, et al. "Autonomous Detection and Classification of PI-RADS Lesions in an MRI Screening Population Incorporating Multicenter-Labeled Deep Learning and Biparametric Imaging: Proof of Concept." Diagnostics (Basel, Switzerland) vol. 10,11 (2020). doi: https://doi.org/10.3390/diagnostics10110951
Winkel DJ, Wetterauer C, Matthias MO, Lou B, Shi B, Kamen A, Comaniciu D, Seifert HH, Rentsch CA, Boll DT. Autonomous Detection and Classification of PI-RADS Lesions in an MRI Screening Population Incorporating Multicenter-Labeled Deep Learning and Biparametric Imaging: Proof of Concept. Diagnostics (Basel). 2020 Nov 14;10(11). doi: 10.3390/diagnostics10110951. PMID: 33202680; PMCID: PMC7697194.
Copy Download .nbib Format: NLM
Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens.

The Journal of pathology

Servant R, Garioni M, Vlajnic T, Blind M, Pueschel H, Müller DC, Zellweger T, Templeton AJ, Garofoli A, Maletti S, Piscuoglio S, Rubin MA, Seifert H, Rentsch CA, Bubendorf L, Le Magnen C.
PMID: 33934365
J Pathol. 2021 Aug;254(5):543-555. doi: 10.1002/path.5698. Epub 2021 Jun 02.

Patient-derived organoids (PDOs) represent promising preclinical models in various tumor types. In the context of prostate cancer (PCa), however, their establishment has been hampered by poor success rates, which impedes their broad use for translational research applications. Along with...

Cite
Servant R, Garioni M, Vlajnic T, et al. Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens. J Pathol. 2021;254(5):543-555doi: 10.1002/path.5698.
Servant, R., Garioni, M., Vlajnic, T., Blind, M., Pueschel, H., Müller, D. C., Zellweger, T., Templeton, A. J., Garofoli, A., Maletti, S., Piscuoglio, S., Rubin, M. A., Seifert, H., Rentsch, C. A., Bubendorf, L., & Le Magnen, C. (2021). Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens. The Journal of pathology, 254(5), 543-555. https://doi.org/10.1002/path.5698
Servant, Raphaëlle, et al. "Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens." The Journal of pathology vol. 254,5 (2021): 543-555. doi: https://doi.org/10.1002/path.5698
Servant R, Garioni M, Vlajnic T, Blind M, Pueschel H, Müller DC, Zellweger T, Templeton AJ, Garofoli A, Maletti S, Piscuoglio S, Rubin MA, Seifert H, Rentsch CA, Bubendorf L, Le Magnen C. Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens. J Pathol. 2021 Aug;254(5):543-555. doi: 10.1002/path.5698. Epub 2021 Jun 02. PMID: 33934365; PMCID: PMC8361965.
Copy Download .nbib Format: NLM
Effect of chondroitin sulfate on osteogenetic differentiation of human mesenchymal stem cells.

Materials science & engineering. C, Materials for biological applications

Schneiders W, Rentsch C, Rehberg S, Rein S, Zwipp H, Rammelt S.
PMID: 34062677
Mater Sci Eng C Mater Biol Appl. 2012 Oct 01;32(7):1926-1930. doi: 10.1016/j.msec.2012.05.036. Epub 2012 May 27.

Chondroitin sulfate (CS) has anti-inflammatory properties and increases the regeneration ability of injured bone. In different in vivo investigations on bone defects the addition of CS to calcium phosphate bone cement has lead to an enhanced bone remodeling and...

Cite
Schneiders W, Rentsch C, Rehberg S, et al. Effect of chondroitin sulfate on osteogenetic differentiation of human mesenchymal stem cells. Mater Sci Eng C Mater Biol Appl. 2012;32(7):1926-1930doi: 10.1016/j.msec.2012.05.036.
Schneiders, W., Rentsch, C., Rehberg, S., Rein, S., Zwipp, H., & Rammelt, S. (2012). Effect of chondroitin sulfate on osteogenetic differentiation of human mesenchymal stem cells. Materials science & engineering. C, Materials for biological applications, 32(7), 1926-1930. https://doi.org/10.1016/j.msec.2012.05.036
Schneiders, Wolfgang, et al. "Effect of chondroitin sulfate on osteogenetic differentiation of human mesenchymal stem cells." Materials science & engineering. C, Materials for biological applications vol. 32,7 (2012): 1926-1930. doi: https://doi.org/10.1016/j.msec.2012.05.036
Schneiders W, Rentsch C, Rehberg S, Rein S, Zwipp H, Rammelt S. Effect of chondroitin sulfate on osteogenetic differentiation of human mesenchymal stem cells. Mater Sci Eng C Mater Biol Appl. 2012 Oct 01;32(7):1926-1930. doi: 10.1016/j.msec.2012.05.036. Epub 2012 May 27. PMID: 34062677.
Copy Download .nbib Format: NLM
Quantitative Determination of Resin Loading in Solid-Phase Organic Synthesis Using (13)C MAS NMR.

Journal of combinatorial chemistry

Hany R, Rentsch D, Dhanapal B, Obrecht D.
PMID: 11148068
J Comb Chem. 2001 Jan 08;3(1):85-89. doi: 10.1021/cc000066q.

The use of quantitative carbon nuclear magnetic resonance spectroscopy ((13)C NMR) for the determination of resin loadings has been investigated. Magic angle spinning (MAS) NMR spectra have been obtained for solvent-swollen resins on a conventional 7 mm CP/MAS probe...

Cite
Hany R, Rentsch D, Dhanapal B, et al. Quantitative Determination of Resin Loading in Solid-Phase Organic Synthesis Using (13)C MAS NMR. J Comb Chem. 2001;3(1):85-89doi: 10.1021/cc000066q.
Hany, R., Rentsch, D., Dhanapal, B., & Obrecht, D. (2001). Quantitative Determination of Resin Loading in Solid-Phase Organic Synthesis Using (13)C MAS NMR. Journal of combinatorial chemistry, 3(1), 85-89. https://doi.org/10.1021/cc000066q
Hany, et al. "Quantitative Determination of Resin Loading in Solid-Phase Organic Synthesis Using (13)C MAS NMR." Journal of combinatorial chemistry vol. 3,1 (2001): 85-89. doi: https://doi.org/10.1021/cc000066q
Hany R, Rentsch D, Dhanapal B, Obrecht D. Quantitative Determination of Resin Loading in Solid-Phase Organic Synthesis Using (13)C MAS NMR. J Comb Chem. 2001 Jan 08;3(1):85-89. doi: 10.1021/cc000066q. PMID: 11148068.
Copy Download .nbib Format: NLM
Activation of cGMP-Dependent Protein Kinase Restricts Melanoma Growth and Invasion by Interfering with the EGF/EGFR Pathway.

The Journal of investigative dermatology

Quadri M, Comitato A, Palazzo E, Tiso N, Rentsch A, Pellacani G, Marconi A, Marigo V.
PMID: 34265328
J Invest Dermatol. 2022 Jan;142(1):201-211. doi: 10.1016/j.jid.2021.06.011. Epub 2021 Jul 13.

Drug resistance mechanisms still characterize metastatic melanoma, despite the new treatments that have been recently developed. Targeting of the cGMP/protein kinase G pathway is emerging as a therapeutic approach in cancer research. In this study, we evaluated the anticancer...

Cite
Quadri M, Comitato A, Palazzo E, et al. Activation of cGMP-Dependent Protein Kinase Restricts Melanoma Growth and Invasion by Interfering with the EGF/EGFR Pathway. J Invest Dermatol. 2021;142(1):201-211doi: 10.1016/j.jid.2021.06.011.
Quadri, M., Comitato, A., Palazzo, E., Tiso, N., Rentsch, A., Pellacani, G., Marconi, A., & Marigo, V. (2022). Activation of cGMP-Dependent Protein Kinase Restricts Melanoma Growth and Invasion by Interfering with the EGF/EGFR Pathway. The Journal of investigative dermatology, 142(1), 201-211. https://doi.org/10.1016/j.jid.2021.06.011
Quadri, Marika, et al. "Activation of cGMP-Dependent Protein Kinase Restricts Melanoma Growth and Invasion by Interfering with the EGF/EGFR Pathway." The Journal of investigative dermatology vol. 142,1 (2022): 201-211. doi: https://doi.org/10.1016/j.jid.2021.06.011
Quadri M, Comitato A, Palazzo E, Tiso N, Rentsch A, Pellacani G, Marconi A, Marigo V. Activation of cGMP-Dependent Protein Kinase Restricts Melanoma Growth and Invasion by Interfering with the EGF/EGFR Pathway. J Invest Dermatol. 2022 Jan;142(1):201-211. doi: 10.1016/j.jid.2021.06.011. Epub 2021 Jul 13. PMID: 34265328.
Copy Download .nbib Format: NLM
Activity of five antimicrobial peptides against periodontal as well as non-periodontal pathogenic strains.

Journal of oral microbiology

Enigk K, Jentsch H, Rodloff AC, Eschrich K, Stingu CS.
PMID: 33133417
J Oral Microbiol. 2020 Oct 07;12(1):1829405. doi: 10.1080/20002297.2020.1829405.

No abstract available.

Cite
Enigk K, Jentsch H, Rodloff AC, et al. Activity of five antimicrobial peptides against periodontal as well as non-periodontal pathogenic strains. J Oral Microbiol. 2020;12(1):1829405doi: 10.1080/20002297.2020.1829405.
Enigk, K., Jentsch, H., Rodloff, A. C., Eschrich, K., & Stingu, C. S. (2020). Activity of five antimicrobial peptides against periodontal as well as non-periodontal pathogenic strains. Journal of oral microbiology, 12(1), 1829405. https://doi.org/10.1080/20002297.2020.1829405
Enigk, Katharina, et al. "Activity of five antimicrobial peptides against periodontal as well as non-periodontal pathogenic strains." Journal of oral microbiology vol. 12,1 (2020): 1829405. doi: https://doi.org/10.1080/20002297.2020.1829405
Enigk K, Jentsch H, Rodloff AC, Eschrich K, Stingu CS. Activity of five antimicrobial peptides against periodontal as well as non-periodontal pathogenic strains. J Oral Microbiol. 2020 Oct 07;12(1):1829405. doi: 10.1080/20002297.2020.1829405. PMID: 33133417; PMCID: PMC7580719.
Copy Download .nbib Format: NLM
Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies.

Urologia internationalis

Wetterauer C, Federer-Gsponer JR, Leboutte FDJP, Mona R, Ebbing J, Rentsch CA, Manka L, Seifert HH, Wyler S, Recker F, Kwiatkowski M.
PMID: 34350895
Urol Int. 2021 Jul 20;1-7. doi: 10.1159/000517300. Epub 2021 Jul 20.

INTRODUCTION: Active surveillance (AS) strategies were established to avoid overtreatment of low-risk prostate cancer (PCa) patients. Low tumor volume represents one indication criteria; however, applying this criterion after MRI-targeted prostate biopsies may lead to overestimation of tumor volume; wherefore,...

Cite
Wetterauer C, Federer-Gsponer JR, Leboutte FDJP, et al. Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies. Urol Int. 2021;1-7doi: 10.1159/000517300.
Wetterauer, C., Federer-Gsponer, J. R., Leboutte, F. D. J. P., Mona, R., Ebbing, J., Rentsch, C. A., Manka, L., Seifert, H. H., Wyler, S., Recker, F., & Kwiatkowski, M. (2021). Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies. Urologia internationalis, 1-7. https://doi.org/10.1159/000517300
Wetterauer, Christian, et al. "Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies." Urologia internationalis vol. (2021): 1-7. doi: https://doi.org/10.1159/000517300
Wetterauer C, Federer-Gsponer JR, Leboutte FDJP, Mona R, Ebbing J, Rentsch CA, Manka L, Seifert HH, Wyler S, Recker F, Kwiatkowski M. Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies. Urol Int. 2021 Jul 20;1-7. doi: 10.1159/000517300. Epub 2021 Jul 20. PMID: 34350895.
Copy Download .nbib Format: NLM
Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records .

The British journal of general practice : the journal of the Royal College of General Practitioners

Walker AJ, MacKenna B, Inglesby P, Tomlinson L, Rentsch CT, Curtis HJ, Morton CE, Morley J, Mehrkar A, Bacon S, Hickman G, Bates C, Croker R, Evans D, Ward T, Cockburn J, Davy S, Bhaskaran K, Schultze A, Williamson EJ, Hulme WJ, McDonald HI, Mathur R, Eggo RM, Wing K, Wong AY, Forbes H, Tazare J, Parry J, Hester F, Harper S, O'Hanlon S, Eavis A, Jarvis R, Avramov D, Griffiths P, Fowles A, Parkes N, Douglas IJ, Evans SJ.
PMID: 34340970
Br J Gen Pract. 2021 Oct 28;71(712):e806-e814. doi: 10.3399/BJGP.2021.0301. Print 2021 Nov.

BACKGROUND: Long COVID describes new or persistent symptoms at least 4 weeks after onset of acute COVID-19. Clinical codes to describe this phenomenon were recently created.AIM: To describe the use of long-COVID codes, and variation of use by general...

Cite
Walker AJ, MacKenna B, Inglesby P, et al. Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records . Br J Gen Pract. 2021;71(712):e806-e814doi: 10.3399/BJGP.2021.0301.
Walker, A. J., MacKenna, B., Inglesby, P., Tomlinson, L., Rentsch, C. T., Curtis, H. J., Morton, C. E., Morley, J., Mehrkar, A., Bacon, S., Hickman, G., Bates, C., Croker, R., Evans, D., Ward, T., Cockburn, J., Davy, S., Bhaskaran, K., Schultze, A., Williamson, E. J., Hulme, W. J., McDonald, H. I., Mathur, R., Eggo, R. M., Wing, K., Wong, A. Y., Forbes, H., Tazare, J., Parry, J., Hester, F., Harper, S., O'Hanlon, S., Eavis, A., Jarvis, R., Avramov, D., Griffiths, P., Fowles, A., Parkes, N., Douglas, I. J., Evans, S. J. (2021). Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records . The British journal of general practice : the journal of the Royal College of General Practitioners, 71(712), e806-e814. https://doi.org/10.3399/BJGP.2021.0301
Walker, Alex J, et al. "Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records ." The British journal of general practice : the journal of the Royal College of General Practitioners vol. 71,712 (2021): e806-e814. doi: https://doi.org/10.3399/BJGP.2021.0301
Walker AJ, MacKenna B, Inglesby P, Tomlinson L, Rentsch CT, Curtis HJ, Morton CE, Morley J, Mehrkar A, Bacon S, Hickman G, Bates C, Croker R, Evans D, Ward T, Cockburn J, Davy S, Bhaskaran K, Schultze A, Williamson EJ, Hulme WJ, McDonald HI, Mathur R, Eggo RM, Wing K, Wong AY, Forbes H, Tazare J, Parry J, Hester F, Harper S, O'Hanlon S, Eavis A, Jarvis R, Avramov D, Griffiths P, Fowles A, Parkes N, Douglas IJ, Evans SJ. Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records . Br J Gen Pract. 2021 Oct 28;71(712):e806-e814. doi: 10.3399/BJGP.2021.0301. Print 2021 Nov. PMID: 34340970; PMCID: PMC8340730.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 168 entries